Onconova Therapeutics CEO Steven Fruchtman's 2023 pay slips 17% to $1.1M
Onconova Therapeutics reports 2023 executive compensation
By ExecPay News
Published: October 11, 2024
Onconova Therapeutics reported fiscal year 2023 executive compensation information on October 11, 2024.
In 2023, three executives at Onconova Therapeutics received on average a compensation package of $751K, a 21% decrease compared to previous year.
Average pay of disclosed executives at Onconova Therapeutics
Steven M. Fruchtman, Chief Executive Officer, received $1.1M in total, which decreased by 17% compared to 2022. 60% of Fruchtman's compensation, or $660K, was in salary. Fruchtman also received $233K in bonus, $132K in option awards, $51K in stock awards, as well as $26K in other compensation.
Mark P. Guerin, Chief Financial Officer, received a compensation package of $746K, which decreased by 12% compared to previous year. 67% of the compensation package, or $500K, was in salary.
Victor Moyo, Chief Medical Officer, earned $405K in 2023.
Related executives
You may also like
Source: SEC filing on October 11, 2024.